Depp Gaikwad

Depp Gaikwad

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report.

Followers 1
Following 0
Contrast Media Market InsightThe contrast media/ contrast agents market is making significant strides over recent years, mainly due to the rapidly developing medical imaging technologies.The healthcare sector is burgeoning and medical imaging technology & techniques are advancing profusely.These advancements have improved the utilization of the existing contrast media while presenting innovative agents.According to Market Research Future (MRFR), the Global Contrast Media Market size is estimated to increase exponentially by 2025, registering approximately 3.5% CAGR during the review period (2019 – 2025).Contrast Media Market Major PlayersPlayers active in the global contrast media market include NanoScan Imaging (US), Bayer Healthcare Pharmaceuticals (Germany), Daiichi (Japan), Medrad Inc. (US), Guerbet Group (France), Subhra Pharma Private Limited (India), GE Healthcare (US), nanoPET Pharma GmbH (Germany), Covidien (Ireland), AMAG Pharmaceuticals (US), CMC Contrast AB (Sweden), Targeson (US), Mallinckrodt Pharmaceuticals (UK), Lantheus Medical Imaging (US), and Bracco Diagnostic Inc. (Italy), among others.Global Contrast Media Market – SegmentsThe analysis has been segmented into six main dynamics.By Type: Iodinated Contrast Media and Gadolinium-Based Contrast Media, and others.By Form:Tablet, Powder, Liquid, and Paste.By Procedure: Computed Tomography, X-ray, Ultrasound, Magnetic Resonance Imaging, and other procedures.By Application: Oncology, Cardiovascular Disorders, Nephrological Disorders, and others.By Route of Administration: Injectable, Oral, and Rectal.By Regions:Asia Pacific, North America, Europe, and the Rest-of-the-World.
Market HighlightsThe Global Skin Tightening Market is forecasted to be valued at USD 6,340.99 Million by 2025 with the CAGR of 6.2% during the forecast period of 2019–2025.According to International Society of Aesthetic Plastic Surgery (ISAPS), in 2016, estimated the total procedure for skin tightening performed worldwide are 511,481 out of which Japan held the highest number of procedures followed by the US.The factors that propel the growth of the market are growing geriatric population, increasing advancement in medical technology and the emerging medical aesthetic market.However, the radiation emitted from skin tightening equipment involve high health-related risk and the stringent government regulations for aesthetic in healthcare is hampering the growth of the skin tightening market.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8245 In the current scenario, several players are dominating the global skin tightening market.For instance, in January 2017, Lynton Lasers launched a stand-alone platform, LUMINA laser & IPL platform, which can perform 24 different aesthetic concern including skin tightening.Regional AnalysisThe global skin tightening market, by region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The skin tightening market in Asia-Pacific region is expected to be the fastest-growing market, due to increasing research and development funding by the developing countries like China and India for the development of the healthcare sector.The skin tightening market in the Middle East & Africa region has less economic developments and extremely low-income, therefore anticipated to have the least market share but is expected to grow with better opportunities in the coming years.Segmental AnalysisThe global skin tightening market has been segmented based on type, portability, application, end user, and region.The market, based on type, has been divided into radiofrequency skin tightening, laser skin tightening, ultrasound skin tightening, and others.
Market ScenarioThe global durable medical equipment market is expected to grow significantly over the forecast period.It is anticipated that the market held a market value of USD 1,08,553.8 million in 2018 and is projected to grow at 6% CAGR over the forecast period.Medical equipment can be classified into two types disposable medical equipment and durable medical equipment.The medical devices such as insulin pump, ostomy bags, and hospital furniture are considered under durable medical equipment and are used for years.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2676  The growing geriatric patient population, rising demand for medical equipment, and growing technological innovation in the medical devices industry are boosting the market growth.The different private insurance companies provide insurance coverage for medical equipment drives market growth.However, the high maintenance and equipment cost, stringent government regulation, and lack of skilled professionals to handle this equipment can hamper the market growth over the forecast period.The bathroom safety devices segment has been sub-segmented into commode, toilet, and others.The global market, by end user, has been segmented into hospital/clinic, ambulatory surgical center, research centers, home healthcare, and others.The durable medical equipment market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The durable medical equipment market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.The increasing patient population, presence of a large number of medical device companies, and rising demand for innovative medical equipment drive the market growth in this region.The European durable medical equipment market has been segmented into Western Europe and Eastern Europe.
Market HighlightsThe Global Molecular Diagnostics Market is expected to register a CAGR of 8.57% during the forecast period, with a market value of USD 16,319.09 Million by 2025.Molecular diagnostics is a collection of techniques used to analyze biological markers in genome and proteome.For instance, as per a survey carried out by the World Health Organisation (WHO), around 9.6 million deaths caused by cancer were recorded in 2018 globally.However, stringent regulatory policies are likely to restrain the market growth during the forecast period.Segment AnalysisThe global molecular diagnostics market has been segmented into product, technique, application, and end user.By product, the market has been segregated into reagents & kits, instruments, and services & software.On the basis of technique, the market has been divided into polymerase chain reaction (PCR), isothermal amplification, hybridization, sequencing, microarray, and others.Based on application, the market has been bifurcated into infectious diseases, oncology, genetic tests, and others.
Market HighlightsThe global theranostics market size accounted for USD 7,968.4 million in 2018 and is projected to grow at a CAGR of 11.4% over the forecast period.Theranostics is a proposed diagnostic methodology for personalizing therapeutic intervention and the integration of imaging and therapy in a single system, enabling simultaneous therapy and follow-up of the treatment.Some of the market growth factors are increasing development of novel companion diagnostic tests, emerging use of theranostics, increasing partnerships and collaborations by major market players to develop innovative companion diagnostics, and rising burden of chronic diseases.In contrast, lack of proper defined regulations for theranostics tests and inadequate reimbursement facilities in most of the countries are anticipated to impede the market growth during the forecast period.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8057 Molecular theranostics is a major field which includes small biochemical moieties and biomacromolecules.Theranostics is important for personalized as well as precision medicine that provides therapeutic outcome so that a physician can make a decision pertaining to the course of treatment for the patient.SegmentationThe global theranostics market has been segmented into the therapeutic area, technology, end user, and region.By therapeutic area, the market has been segmented into oncology, cardiovascular diseases, neurological disorders, immunological disorders, and others.The oncology segment is further categorized into breast cancer, colorectal cancer, lung cancer, cervical cancer, and others.On the basis of technology, the market has been divided into polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), sequencing, and others.
Market HighlightsThe active pharmaceutical ingredient (API) market globally is expected to expand with a CAGR of 4.93 percent during the forecast period while earning revenues past the USD 215 billion mark by the year 2023.The expiration of patents of branded drugs has created a serious impression on drug manufacturers, as the companies can incur tremendous losses after expiration.The generics are also expected to be the most rapidly growing type due to patent expirations of many blockbuster drugs.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1385 Active Pharmaceutical Ingredients or API, in short, are growing in an increscent manner due to the unmatched effects of active chemicals in the drugs and the portions that work on treating the condition.The bridging of foreign manufacturers and local distributors has led to extensive progress in the market over the past few years.The generics are also expected to be the most rapidly growing type due to patent expirations of many blockbuster drugs.However, the rapidly increasing scope for high-potency active pharmaceutical ingredients over the last decade has shifted the focus to the new biologics gold rush of recombinant proteins and monoclonal antibodies.The small molecule segment is expected to maintain its top position till the end of 2023.
Market HighlightsThe Global eClinical Solutions Market is estimated to be valued at USD 9434.57 million by 2023 and is expected to register a CAGR of 12.24% during the forecast period.The clinical data management system (CDMS) dominated the global eClinical solutions market, by type, and is projected to reach USD 2579 million by 2023 owing to the benefits offered by the product such as centralized end-to-end management of clinical trial activities, real-time status tracking, elimination of reliance on manual processes, and maintenance of multiple databases, which improve the overall efficiency of clinical trials.However, the electronic clinical outcome assessment (eCOA) segment is projected to be the fastest-growing segment during the forecast period.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2294 Americas dominated the market, accounting for the largest share of the market in 2017, and the regional market is expected to register a CAGR of 12.41% during the review period.The market is projected to reach USD 4568.70 million by the end of 2023, with the US being the leading market.Segment AnalysisThe global eClinical solutions market has been segmented on the basis of type, delivery mode, clinical trial phase, and end user.On the basis of type, the market has been divided into the clinical data management system (CDMS), randomization and trial supply management (RTSM), electronic clinical outcome assessment (eCOA), clinical trial management system (CTMS), electronic trial master files (eTMF), and trial safety & regulatory.The Clinical Data Management System (CDMS) segment held the majority market share in 2017.However, the Electronic Clinical Outcome Assessment (eCOA) segment is anticipated to be the fastest growing, followed by the Clinical Data Management System (CDMS) segment.On the basis of Delivery Mode, the market has been divided into web-based, cloud-based, and enterprise-based.Based on Clinical Trial Phase, the market has been segmented into Phase I, Phase II, Phase III, Phase IV.
Market HighlightsThe global feminine hygiene market was valued at USD 21.96 Billion in 2018.The market is projected to register a CAGR of 7.2 % during the forecast period of 2019 to 2024.Numerous factors, such as the rising disposable income of the middle class in emerging countries such as Brazil and China, and the emergence of low-cost feminine hygiene products.However, the increasing number of product recalls due to several factors such as the growing allergy cases among women and the presence of toxic chemicals in feminine products are anticipated to hinder the growth of the global feminine hygiene marketBrowse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7986 SegmentationThe global feminine hygiene market, based on product type, has been segmented into sanitary napkins/pads, tampons, panty liners, menstrual cups, and feminine hygiene wash.The market, by distribution channel, has been segmented into supermarket and department stores, retail pharmacies, online retail stores, and others.Supermarkets and department stores segment are expected to hold the major share as a majority of women tend to purchase sanitary items along with household items.Key PlayersSome of the key players in the global feminine hygiene market are Johnson & Johnson, Procter and Gamble, Edgewell Personal Care, Unicharm Corporation, Ontex International, Svenska Cellulosa Aktiebolaget SCA, Kimberly-Clark Corporation, Lil-Lets Group Ltd, Natracare LLC, and Kao Corporation.Regional AnalysisGeographically, Asia-Pacific region is anticipated to dominate the global feminine hygiene market due to various factors such as the rising disposable income of the middle-class population, especially in countries such as China and India which has led to rising in women’s buying quality hygiene products.Additionally, the growing awareness about feminine hygiene products owing to several initiatives taken by the government and the non-government organization in this region is anticipated to boost the market growth.Americas is expected to hold a second market position in the global feminine hygiene market.
Market HighlightsGlobal digital radiology devices market expected to grow significantly over the forecast period.It is anticipated that the market held a market value of USD 8146.54 million in 2018 and is projected to grow at a CAGR of 10.8% over the forecast period.The global digital radiology devices market is growing at a rapid pace, the major factors influencing the growth of the market include; increasing geriatric population, increasing prevalence of chronic and dental diseases.Cardiovascular imaging, chest imaging, and dental imaging have been few of the major application of digital radiology device.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7973 Chronic diseases and conditions are increasing rapidly worldwide.According to the World Health Organization (WHO), the amount of the burden of chronic diseases is expected to increase to 60% by 2020, and 79% of deaths due to these diseases would occur in developing countries.This increasing chronic disease is influencing the growth of the market.Moreover, dental imaging has also been one of the fastest growing segments for digital radiology market.Dental Imaging and digital radiology have been a preferred imaging methodology for comprehensive orthodontic treatment all around the globe.
The Global Lancet Market Registered a CAGR of 10.50% during the assessment period, with a market value of USD 1,595.5 Million in 2018.Lancets are being used for diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or severely burned patients.However, the risk associated with blood transfusion is expected to hinder the market growth during the forecast period.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2078 Market DynamicsOne of the major applications or functioning areas of lancets is to monitor diabetes in the diabetic population.According to the Centers for Disease Control and Prevention (CDC), 9.4% of the US population are diabetic patients.With the increasing prevalence of diabetes, the demand for lancets is expected to be enormous, thus resulting in the increasing demand for devices and products to monitor and control diabetes, eventually leading to increased use of lancets.SegmentationThe global lancet market based on type has been segmented into safety lancet and personal lancet.Safety lancets can be further divided into push-button safety lancets; pressure activated safety lancets and side button safety lancets.Based on end user, the market is segmented into the hospitals & clinics, diagnostic centers & pathology laboratories, home diagnostics, research and academic laboratories, and others.
Market ScenarioThe global radiology services market accounted for USD 8,102.51 million in 2018 and is expected to register a CAGR of 10.5% during the forecast period (2019–2024).Radiology is the technology that diagnosis and treat diseases within the human body by using medical imaging.The radiology services are served by the radiologists and experts that are qualified for performing the test and have unique postgraduate medical education in, radiation effects on the human body, radiation safety/protection, appropriate performance and interpretation of quality radiologic, and medical imaging examinations.Radiology services comprise X-Rays, computed tomography (CT), ultrasound, fusion imaging, positron emission tomography (PET), nuclear medicine, and magnetic resonance imaging (MRI).This will help to reduce the regulatory burden on the medical device industry.However, the risk of high radiation exposure associated with the devices may hamper the growth of the market during the assessment period.SegmentationThe global radiology services market has been segmented on the basis of product type, application, technology, end user, and region.On the basis of product type, the market has been classified as stationary digital radiology systems and portable digital radiology systems.The stationary digital radiology segment is expected to hold the largest market share of the radiology services market due to acceptance of stationary systems in hospitals, extensive application, and less exposure to radiation.However, portable digital radiology segment is showing the highest growth rate owing to simplicity in the workflow, low-cost, and proficiency performing complex computational tasks.The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
Market HighlightsThe global flat panel detector (FPD) market held a market value of USD 3.06 Billion in 2018 and is projected to grow at a CAGR of 6.7% over the forecast period.Flat panel detector (FPD) is a type of solid-state X-ray digital radiography device.It works in the same way as image sensors used in digital photography and video works.Growing public and private investments in digital imaging technologies and declining prices and benefits offered by digital detectors are positively affecting market growth.Additionally, growing medical tourism in developing countries is also expected to drive the market growth.Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7903 On the other hand, the high cost of the system is likely to hamper the growth of the market.SegmentationThe global flat panel detector (FPD) market has been segmented by portability, application, and end user.By portability, the market has been segmented into fixed and portable.The portable flat panel detector is expected to show the largest market share.By application, the market has been segmented into medical, orthopedic, cardiac, veterinary, mammogram, dental, and others.The market, by end user, has been segmented into hospitals and clinics, and diagnostic centers.Key PlayersSome of the prominent players in the global flat panel detector (FPD) market are General Electric Company, Carestream Health, Canon Medical Systems Corporation, Fujifilm Holdings America Corporation, PerkinElmer Inc., Trixell, iRay Technology, Varian Medical Systems, Inc., Agfa-Gevaert Group, New Medical Imaging Co., Ltd, Varex Imaging Corporation, Imaging Dynamics Company Ltd and others.Regional AnalysisOn a regional basis, the Americas is anticipated to dominate the global flat panel detector (FPD) market owing to the technological innovations, increasing healthcare spending, availability of venture capital and government funding, and increasing incidence of chronic diseases in the region has fueled the growth of the market.
Market HighlightsThe Global Autoinjectors Market is Estimated to be Valued at USD 79,741 Million by 2024 and is Expected to Register a CAGR of 17.42% During the Forecast Period.The disposable autoinjectors segment is expected to lead the market and register a substantial CAGR to reach USD 53,696.20 Million by the end of 2024.The increasing demand for testing new drugs and chemicals and vigorous growth in the pharmaceutical and biopharmaceutical sectors are expected to drive the market growth.Additionally, the disposable autoinjectors segment is also projected to exhibit the highest CAGR of 17.90% from 2019 to 2024.Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6311 Americas accounted for the largest market share of 40.6% in 2018, and the regional market is projected to register a CAGR of 16.60% during the forecast period.The Indian market is projected to exhibit the highest growth rate of 18.95% during the forecast period of 2019 to 2024.Segment AnalysisThe Global Autoinjectors Market has been segmented on the basis of product type, design therapeutic application, distribution channel, and region.The disposable autoinjectors segment held the majority market share in 2018.
Market HighlightsThe Global Laparoscopy Devices Market Is Estimated To Be Valued At USD 17,206.32 Million By 2023 And Expected To Grow At A CAGR Of 8.30% During The Forecast Period.Laparoscopy devices are used in surgical procedures that permit a surgeon to access the inside of the abdomen and pelvis without having to make large incisions in the skin.This laparoscopic surgical procedure is also known as keyhole surgery or minimally invasive surgery.Laparoscopy devices capture images in the stomach, small intestine, and pelvic system which are utilized for the diagnosis of various intestinal, gynecological, and urological diseases.Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6312 The demand for laparoscopic surgical procedures is rising due to major benefits associated with these surgeries such as small or no incision, short hospital stays, less pain, quick recovery time, less scarring, and reduction in blood loss.Market Research Future (MRFR) recognizes the following companies as the key players in the global laparoscopy devices market that includes:  Becton, Dickinson and Company (US), Smith & Nephew PLC (UK), B. Braun Melsungen AG (Germany), Medtronic PLC (US), Cook Medical LLC (US), Fujifilm Holdings Corporation (Japan), Olympus Corporation (Japan), Stryker Corporation (US), KARL STORZ SE & Co. KG (Germany), Richard Wolf GmbH (Germany), and others.Segment analysisGlobal laparoscopy devices market has been segmented on the basis of product, application, and end user.On the basis of product, the global laparoscopy devices market has been segmented into laparoscopes, energy devices, insufflation devices, suction/irrigation devices, handheld instruments, access devices, trocars, internal closure devices, and others.The general surgery segment accounts for a major share with 7.79% CAGR during the forecast period.
More

Top